[CIS-PAGID] Chr 22q11.2 duplication

Vivian Hernandez-trujillo drbibi at pol.net
Tue Feb 14 21:38:27 EST 2012


Dear Joe-

We have the same experience in Miami.

Viv
----- Original Message -----
From: "Joseph Church" <JChurch at chla.usc.edu>
To: pagid at list.clinimmsoc.org
Sent: Tuesday, February 14, 2012 8:03:13 PM GMT -05:00 US/Canada Eastern
Subject: Re: [CIS-PAGID] Chr 22q11.2 duplication




Thanks, Kate.  Exactly what I needed.  JC

 



From: pagid-bounces at list.clinimmsoc.org [mailto:pagid-bounces at list.clinimmsoc.org] On Behalf Of Kate Sullivan
Sent: Tuesday, February 14, 2012 4:52 PM
To: pagid at list.clinimmsoc.org
Subject: Re: [CIS-PAGID] Chr 22q11.2 duplication

 

We have found a number here and while they have many featured in common with the deletions, they have not (so far) had an immune deficiency.


 


Kate



Kate Sullivan, MD PhD
Professor of Pediatrics
ARC 1216 Immunology CHOP
3615 Civic Center Blvd.
Philadelphia, PA 19104
(p) 215-590-1697


(f) 267-426-0363

 



On Feb 14, 2012, at 6:09 PM, Church, Joseph wrote:







Colleagues:


 


I have been asked to see a 1yo with congenital anomalies, chronic lung disease, PDA ligation and coarc repair, and acute pneumonia.  The patient phenotypically looks like a DiGeorge patient.  She has chr 22q11.2   duplication .


 


Do patients with 22q.11.2   duplication   have immunodeficiency?


 


Thank you.


 


Joe Church


Children's Hospital Los Angeles


 


 


---------------------------------------------------------------------
CONFIDENTIALITY NOTICE: This e-mail message, including any attachments,  
is for the sole use of the intended recipient(s) and may contain confidential
or legally privileged information. Any unauthorized review, use, disclosure
or distribution is prohibited. If you are not the intended recipient, please
contact the sender by reply e-mail and destroy all copies of this original message.  
---------------------------------------------------------------------

 


---------------------------------------------------------------------
CONFIDENTIALITY NOTICE: This e-mail message, including any attachments,
is for the sole use of the intended recipient(s) and may contain confidential
or legally privileged information. Any unauthorized review, use, disclosure
or distribution is prohibited. If you are not the intended recipient, please
contact the sender by reply e-mail and destroy all copies of this original message.
---------------------------------------------------------------------



More information about the PAGID mailing list